Fig. 1 · Structure
Documents & Downloads
AF-CX 1325
Antiepileptic Agent
AF-CX 1325 is an innovative antiepileptic agent that exerts its effects through modulation of neuronal excitability. This compound demonstrates significant activity in reducing seizure frequency and intensity, making it suitable for the study of epilepsy pharmacotherapy. Research applications include exploring its mechanisms of action and its potential for use in combination therapies for epilepsy management.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 88708-96-7 |
| Applications | Antiepileptic Agent |
| Formula | C15H11NO2S |
| Molecular Weight | 269.32 |
| SMILES | O=C(C1=CC=CC=C1S/2=O)C2=C(C3=CC=CC=C3)/N |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.